PMC8565681_01
Bilateral mammogram showing a 40 mm mass in the right breast, behind the nipple, with multiple microcalcifications (a) and a 90/75 mm mass in the left breast (b).
acc-06-03-69-g001.jpg
PMC8565681_01_acc-06-03-69-g001.jpg
acc-06-03-69-g001
After performing a mammogram (Figure 1), breast ultrasound and elastography, breast MRI (Figure 2), the diagnosis was bilateral luminal B breast cancer - invasive carcinoma NST, Nottingham II, ER= 70%, PR= 3%, HER2= 1+(negative), Ki67= 40%, in the left breast and invasive carcinoma NST, Nottingham II, ER= 60%, PR= 1%, HER2= 0 (negative), Ki67= 50%, in the right breast.
Bilateral mammogram showing a mass with 90/75 mm on the left breast and a right mass behind the nipple with multiple microcalcifications, measuring 40 mm.
acc-06-03-69-g002.jpg
PMC8565681_01_acc-06-03-69-g002.jpg
acc-06-03-69-g002
After performing a mammogram (Figure 1), breast ultrasound and elastography, breast MRI (Figure 2), the diagnosis was bilateral luminal B breast cancer - invasive carcinoma NST, Nottingham II, ER= 70%, PR= 3%, HER2= 1+(negative), Ki67= 40%, in the left breast and invasive carcinoma NST, Nottingham II, ER= 60%, PR= 1%, HER2= 0 (negative), Ki67= 50%, in the right breast.
FDG-PET-CT: (a) coronal section, active areas on the intestinal ansae (max SUV= 9.7); (b) axial section, active area on the lower quadrant (max SUV= 9.7).
acc-06-03-69-g003.jpg
PMC8565681_01_acc-06-03-69-g003.jpg
acc-06-03-69-g003
Brain CT, axial section, brainstem lesion measuring 20 mm (red arrow).
acc-06-03-69-g004.jpg
PMC8565681_01_acc-06-03-69-g004.jpg
acc-06-03-69-g004
Brain CT, axial section, brainstem lesion measuring 14 mm (red arrow).
acc-06-03-69-g005.jpg
PMC8565681_01_acc-06-03-69-g005.jpg
acc-06-03-69-g005
A partial response by RECIST 1.1 criteria (60% reduction) was obtained after 3 months (Figure 5).
Brain CT, axial section, brainstem lesion measuring 23 mm (red arrow).
acc-06-03-69-g006.jpg
PMC8565681_01_acc-06-03-69-g006.jpg
acc-06-03-69-g006
Brain CT, axial section, no evidence of the brainstem lesion.
acc-06-03-69-g007.jpg
PMC8565681_01_acc-06-03-69-g007.jpg
acc-06-03-69-g007
Scheme of regimen and response correlation. 1 - CR (complete response), 2 - PR (partial response), 3 - SD (stable disease), 4 - PD (progression disease).
acc-06-03-69-g008.jpg
PMC8565681_01_acc-06-03-69-g008.jpg
acc-06-03-69-g008